Delivery Order SPE2DB20D7066-SPE2DB25FC3UH
Award Date
6/20/25
Potential Completion Date
6/23/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,839.85, is for the delivery of 4,567,962,457 units of ACTIVASE 50 MG VIALS, a medication used for medical treatment. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for $7,778.45. The contract is for the delivery of ACTIVASE 50 MG VIALS, a medical product, with a completion date of June 4, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $26,175.31 firm-fixed-price contract is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical supplies and pharmaceuticals to various...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,743.76 and is for the delivery of ACTIVASE 50 MG VIALS, a medical product. It is a firm fixed price contract with an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 50 MG VIALS, a medical product, and has a firm fixed-price ceiling value of $9,014.34. The contract is non-set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 50 MG VIALS, a medical product, with a ceiling value of $29,679.70 and a period of performance through February 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,479.90, is for the supply of ACTIVASE 50 MG VIALS medical products. The contract has an ultimate completion date of June 6, 2025 and is not set aside for a particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ACTIVASE 50 MG VIALS, a critical pharmaceutical product. The $9,550.56 firm fixed price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of ACTIVASE 100 MG VIALS. The contract has a ceiling value of $70,291.64 and a period of performance through August 6, 2024. The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide the requested medical product to support military treatment...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ACTIVASE 50 MG VIALS, a medical product, with a ceiling value of $6,219.76 and a period of performance through March 13, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...